| Ticker Details |
Biogen Inc.
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$25.38B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.46 | 1.33%
|
| Avg Daily Range (30 D): |
$2.47 | 1.35%
|
| Avg Daily Range (90 D): |
$2.61 | 1.44%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.06M |
| Avg Daily Volume (30 D): |
.81M |
| Avg Daily Volume (90 D): |
1.16M |
| Trade Size |
| Avg Trade Size (Sh.): |
105 |
| Avg Trade Size (Sh.) (30 D): |
36 |
| Avg Trade Size (Sh.) (90 D): |
41 |
| Institutional Trades |
| Total Institutional Trades: |
44,817 |
| Avg Institutional Trade: |
$6.19M |
| Avg Institutional Trade (30 D): |
$15.15M |
| Avg Institutional Trade (90 D): |
$18.41M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
7 |
| Market Closing Trades |
| Avg Closing Trade: |
$28.49M |
| Avg Closing Trade (30 D): |
$43.66M |
| Avg Closing Trade (90 D): |
$55.58M |
| Avg Closing Volume: |
139.29K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$8.83
|
$-.33
|
$8.83
|
|
Diluted EPS
|
$8.79
|
$-.35
|
$8.79
|
|
Revenue
|
$9.89B
|
$2.28B
|
$9.89B
|
|
Gross Profit
|
$7.49B
|
$1.78B
|
$7.49B
|
|
Net Income / Loss
|
$1.29B
|
$-48.9M
|
$1.29B
|
|
Operating Income / Loss
|
$1.56B
|
$-56M
|
$1.56B
|
|
Cost of Revenue
|
$2.4B
|
$495.5M
|
$2.4B
|
|
Net Cash Flow
|
$633.5M
|
$-854.3M
|
$633.5M
|
|
PE Ratio
|
20.36
|
|
|
|
|
|
